2024

Supporting Organizations: 1bio, Biocentury, Portal Innovations, Banc of California, Phase Capital,
The summit was generously sponsored by:
Croke Fairchild Duarte & Beres, Trammell Crow Company, CDD Vault, Power Construction, ESG Architecture & Design, Prendio BioProcure, ISEC, J.P. Morgan, Lonza, Amgen, Chan Zuckerberg Biohub Chicago, InteliSpark, Deloitte, Xentria, Cytiva, Sheer Velocity, Hollister, Walder Ventures
The Chicago Biochemistry Consortium gratefully acknowledges support from The Searle Funds at the Chicago Community Trust, National Institute of Health, and Walder Foundation.
Chicago BioCapital Summit Highlights
▸ Click here to view full program
- ▸ Speakers
- ▸ Fireside Chat
- ▸ Panel 1
- ▸ Panel 2
- ▸ Panel 3
- ▸ Hall of Inventions
- ▸ Summit Impact
- ▸ Summit Photos
-

Keynote Speaker
Ted Love, Chairman, Biotechnology Innovation Organization (BIO); Former President and CEO, Global Blood Therapeutics, who shared his insights on how “combination technologies” will be most productive for creating new therapies.

Distinguished Speaker (virtual)
George Church, PhD, Robert Winthrop Professor of Genetics, Harvard Medical School, co-founder of 50+ companies, talked about his entrepreneurial journey from CRISPR to GRObio.

Featured Guests
In a candid chat with Jim Audia, EVP Drug Discovery & Early Development, Founding Scientist, FLARE Therapeutics, Steven Paul, Venture Partner, Third Rock Ventures shared his incredible career and the success of Karuna.
-

Fireside Chat
A founder’s perspective on startup to growth and acquisition featuring Shobha Parthasarathi, PhD, Founder and President, Intovis and Erandi de Silva, PhD, Partner, Drive Capital, took a deep dive into what innovation looks like in the Midwest.
-

Panel 1: Attracting capital to emerging biotech hubs
- Tim Walbert, Former Chairman, President and Chief Executive Officer, Horizon Therapeutics; Sr. Advisor, Amgen
- Michal Preminger, Regional Head, Johnson & Johnson Innovation, E. North America
- Stephen Squinto, CIO, J.P. Morgan Life Sciences Private Capital
- Dana Watt, Partner, Breakout Ventures
- Martin Burke, May and Ving Lee Professor for Chemical Innovation, and Professor of Chemistry
- Moderated by Julia Monfrini Peev, Managing Partner, PACE Healthcare Capital
-

Panel 2: Aligning academic discoveries with investors and advisors
- Karen Heidelberger, Partner and Chief Partnerships Officer, Deerfield Management
- Rima Chakrabarti, Venture Partner, KdT
- Anya Schiess, Co-Managing Partner, J.P. Morgan Life Sciences Private Capital
- Chris O’Donnell, Executive Director, WRDM; Partner, Pfizer Ventures
- Mira Chaurushiya, Managing Director, Westlake Village BioPartners
- Matthew McMahon, Director, SEED, NIH
- Moderated by Ritu Shah, Managing Director, Portal Innovations
-

Panel 3: AI in the Life Sciences
- Matej Macak, Partner, McKinsey Quantum Black
- Milind Kamkolkar, Partner, RA Capital
- Renee Yao, Ecosystem Business Development, Healthcare Life Sciences, NVIDIA
- Chris Ghadban, Investor, The Venture Collective
- Moderated by Saif Rathore, Senior Advisor, McKinsey & Company
-
Featured Innovators | Biotech Ecosystem Partners
Featured Innovators
Acorn Genetics (NU) Cardio Diagnostics (UI) Cardiosense (NU) Concilio (UC) Dupage Medical Technology (UIC) Lohman Technologies (UW) Mountview Therapeutics (LCH) Resuscitation Therapeutics (RFU) William Muller, MD, PhD (Faculty) (NU) Paul Goldspink, PhD (Faculty)
Beata Wolska, PhD (Faculty) (UIC)Prenosis (UIUC) Terry Vanden Hoek, MD (Faculty)
Jing Li, MD (Faculty) (UIC)Dimension Inx (NU) Amphix Bio (NU) Trace Biosciences (O) 32 Biosciences (UC)(UW) 3Bar Biologics (OSU) MicroMGX (NU) Yobee Care (NU) BiomeSense (UC) Ali Keshavarzian, MD (Faculty) (RushU) Opera Bioscience (NU) AirAnswers (RFU) Banta Therapeutics (UIC) Claudyn Biotech (UC) (UIC) ClostraBio (UC) COUR Pharmaceuticals (NU) EVOQ Therapeutics (UM) Signl (UC) Syenex (NU) ARTEC Biotech (LCH) Atzeyo Biosensors (UIUC) Serder Bulun, MD (Faculty)
Ping Yin, MD, PhD (Faculty (NU)Eleuthra Photonics (UIUC) Ellis Bio (UC) Aplexis (NU) Sean Fanning, PhD (Faculty) (LUC) Gregor Diagnostics (UW) Anthony Kossiakoff, PhD (Faculty) (UC) Grove Biopharma (NU) Promiss Diagnostics (UW) Shana O. Kelley, PhD(Faculty)
Randy Atwal, PhD (NU)Immuto Scientific (UW) M3D (UM) Irina Balyasnikova, PhD (Faculty) (NU) NovaScan (UW) OrisDX (UC) (O) Modumab Therapeutics (NU) SimBioSys (UIUC) Vortex Therapeutics (NU) Xiaoyu Zhang, PhD (Faculty) (NU) Riptide Therapeutics (UC) Abcon Therapeutics (UC) Saros Therapeutics (UM) Varchas Biotechnologies (NU) Temprian Oncology (NU) Temprian Therapeutics (NU) Vivacelle Bio (O) Briteseed ReAx Biotechnologies (UC) Enzyme by Design (UIC) Clarix Imaging (UC) IMMUNARTES (UC) Irina Nesterova, PhD (Faculty) (NIU) Perseid Medical (UIUC) Synpha Biosciences (UW) Vastimmune Biologics (UIC) Venumadhav Korampally, PhD (Faculty) (NIU) Juan Mendoza, PhD (Faculty) (UC) Sahar Vahabzadeh, PhD (Faculty) (NIU) Loyola Clinical NLP (LUC) Mudassir Rashid, PhD (Faculty) (IIT) Katz Diagnostics (RushU) (NU) Stemloop (NU) Sibel Health (NU) Anapneo (IIT) SNC Therapeutics (NU) (O) Ikaika Therapeutics (NU) Syntax Bio (UIC) Selagine (UIC) Siloam Vision (UIC) (O) Inomagen Therapeutics (NU) Biagon (IIT) Intero Biosystems (UM) SynthBits (UC) CellCipher (UC) (O) Neuroplastica (NU) Cadenza Bio (UIUC) NeuraWorx Medical Technologies (UW) Vanqua Bio (NU) Stem Pharm (UW) Akava Therapeutics (NU) Blue Arbor Technologies (UM) Lysosomal Therapeutics (NU) KeyWise AI (UIC) (O) Peter Penzes, PhD (Faculty)
Euan Parnell, PhD (Faculty) (NU)Sigenics (IIT) Samie Tootooni, PhD (Faculty) (LUC) Rhaeos (NU) Brite Minds Biosciences (UIC) Stream Neuroscience (NIU) (O) Pax Neuroscience (UIC)
Biotech Ecosystem Partners
Office of Technology Management at University of Illinois Chicago INVO/InQbation Lab at Northwestern University Polsky Center at The University of Chicago Rosalind Franklin University of Medicine and Science Center for Health Innovation and Entrepreneurship at Loyola University Illinois Institute of Technology Rush University Discovery Partners Institute Carl R. Woese Institute of Genomic Biology at University of Illinois Urbana-Champaign University of Illinois Urbana-Champaign Northern Illinois University Ann & Robert H. Lurie Children’s Hospital of Chicago Wisconsin Alumno Research Foundation The University of Michigan – Innovation Partnerships The Consortium for Technology & Innovation in Pediatrics NIH NINDS – Small Business Program Federal Laboratory Consortium Illinois Science and Technology Coalition SmartHealth Catalyzer
*Affiliated InstitutionsIIT- Illinois Institute of Technology LCH – Ann & Robert H. Lurie Children’s Hospital of Chicago LUC – Loyola University Chicago OSU – Ohio State University O – Other NIU – Northern Illinois University NU – Northwestern University RFU – Rosalind Franklin University RushU – Rush University UC – University of Chicago UM – University of Michigan UI – University of Iowa UIC – University of Illinois Chicago UIUC – University of Illinois Urbana-Champaign UW- University of Wisconsin
-
Summit Impact
The Chicago BioCapital Summit’s impact extended well beyond the event, with a vibrant online engagement underscoring its success. Summit attendees shared how their participation in the event broadened their perspective on innovation happening in the Midwest. With a clear vision and a collaborative spirit, the 2024 Chicago BioCapital Summit highlighted the Midwest’s potential to become a hub for life science innovation.
“I want to give a loud shoutout to the Chicago Biomedical Consortium for the impressive work to develop the most optimal conditions allowing innovation from Chicago-based universities University of Chicago, University of Illinois Chicago and Northwestern University to be translated toward meaningful products for patients and mobilized into startups and/or industry partners (…)” J&J Innovation
“(…) I had the opportunity to meet many people from different backgrounds and I was impressed by the energy and passion driving the development of the next generation of Midwest Biotech”. Théa Open Innovation
“(…) It was great to see the vibrant Chicago biotech scientists and entrepreneurs architecting new approaches to drug discovery and development. (…)”. RA Capital
-
Summit Photos
This slideshow requires JavaScript.
